{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:38:35Z","timestamp":1792751915748,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.nano.2026.103041","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:34:04Z","timestamp":1792391644000},"page":"103041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineering exosome-based delivery of IL-37 to enhance cytokine stability and antitumor activity in vitro and in vivo"],"prefix":"10.1016","volume":"78","author":[{"given":"Zaheer","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoakusa","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Akram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nano.2026.103041_bb0005","doi-asserted-by":"crossref","DOI":"10.1080\/2331205X.2019.1635806","article-title":"Extracellular vesicles-based drug delivery system for cancer treatment","volume":"6","author":"Balachandran","year":"2019","journal-title":"Cogent Med"},{"key":"10.1016\/j.nano.2026.103041_bb0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jcis.2023.11.156","article-title":"Multifunctional nanoparticles inhibit tumor and tumor-associated macrophages for triple-negative breast cancer therapy","volume":"657","author":"Liu","year":"2024","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"10.1016\/j.nano.2026.103041_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s12951-023-02220-7","article-title":"Nano-modulators with the function of disrupting mitochondrial Ca2+ homeostasis and photothermal conversion for synergistic breast cancer therapy","volume":"21","author":"Wang","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"10.1016\/j.nano.2026.103041_bb0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Th\u00e9ry","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2026.103041_bb0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","article-title":"Using exosomes, naturally-equipped nanocarriers, for drug delivery","volume":"219","author":"Batrakova","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.103041_bb0030","doi-asserted-by":"crossref","first-page":"751079","DOI":"10.3389\/fcell.2021.751079","article-title":"Exosomes, a new star for targeted delivery","volume":"9","author":"Chen","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nano.2026.103041_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2020.100261","article-title":"Exosome engineering: Current progress in cargo loading and targeted delivery","volume":"20","author":"Fu","year":"2020","journal-title":"NanoImpact"},{"issue":"10","key":"10.1016\/j.nano.2026.103041_bb0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1471-4906(01)02034-8","article-title":"Annotating genes with potential roles in the immune system: six new members of the IL-1 family","volume":"22","author":"Dunn","year":"2001","journal-title":"Trends Immunol"},{"issue":"12","key":"10.1016\/j.nano.2026.103041_bb0045","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.1819672116","article-title":"Interleukin-37 monomer is the active form for reducing innate immunity","volume":"116","author":"Eisenmesser","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2026.103041_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2650590","article-title":"Interleukin-37: the effect of anti-inflammatory response in human coronary artery endothelial cells","volume":"2019","author":"Yan","year":"2019","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.nano.2026.103041_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696605","article-title":"Current understanding of IL-37 in human health and disease","volume":"12","author":"Su","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.nano.2026.103041_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-016-0782-4","article-title":"The role of IL-37 in cancer","volume":"33","author":"Ding","year":"2016","journal-title":"Med Oncol"},{"key":"10.1016\/j.nano.2026.103041_bb0065","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s10529-024-03539-3","article-title":"Recombinant expression, downstream optimization, and therapeutic evaluation of recombinant human interleukin-37 for cancer therapy","volume":"46","author":"Abbas","year":"2024","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.nano.2026.103041_bb0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbiotec.2023.06.008","article-title":"Evaluation of exosomes encapsulated recombinant Interleukin-29 for its in vitro anticancer studies","volume":"373","author":"Fujimura","year":"2023","journal-title":"J Biotechnol"},{"key":"10.1016\/j.nano.2026.103041_bb0075","article-title":"Exosomes as drug carriers in anti-cancer therapy","volume":"10","author":"Chen","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nano.2026.103041_bb0080","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.nano.2026.103041_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231994","article-title":"The characterization of exosomes from fibrosarcoma cell and the useful usage of Dynamic Light Scattering (DLS) for their evaluation","volume":"16","author":"Lyu","year":"2021","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.nano.2026.103041_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183490","article-title":"Exosomes isolated from two different cell lines using three different isolation techniques show variation in physical and molecular characteristics","volume":"1863","author":"Dash","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"3","key":"10.1016\/j.nano.2026.103041_bb0095","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"10.1016\/j.nano.2026.103041_bb0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.nano.2026.103041_bb0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40199-019-00280-5","article-title":"Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques","volume":"27","author":"Salarpour","year":"2019","journal-title":"Daru"},{"issue":"4","key":"10.1016\/j.nano.2026.103041_bb0110","first-page":"2639","article-title":"Decreased IL-37 expression in hepatocellular carcinoma tissues and liver cancer cell lines","volume":"19","author":"Li","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.nano.2026.103041_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molimm.2020.03.012","article-title":"Interleukin-37 suppresses hepatocellular carcinoma growth through inhibiting M2 polarization of tumor-associated macrophages","volume":"122","author":"Zhang","year":"2020","journal-title":"Mol Immunol"},{"issue":"9","key":"10.1016\/j.nano.2026.103041_bb0120","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1073\/pnas.1619011114","article-title":"Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance","volume":"114","author":"Cavalli","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.nano.2026.103041_bb0125","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/13813455.2020.1733024","article-title":"Mechanistic exploration of the activities of poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid against hepatocellular carcinoma at cellular and molecular levels","volume":"128","author":"Kumar","year":"2022","journal-title":"Arch Physiol Biochem"},{"issue":"9","key":"10.1016\/j.nano.2026.103041_bb0130","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1478-3231.2010.02314.x","article-title":"Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease","volume":"30","author":"Cal\u00e8s","year":"2010","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.nano.2026.103041_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fshw.2017.12.002","article-title":"Biochemical and histopathological profiling of Wistar rat treated with Brassica napus as a supplementary feed","volume":"7","author":"Hasan","year":"2018","journal-title":"Food Sci Human Wellness"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:46:26Z","timestamp":1792748786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":27,"alternative-id":["S1549963426001425"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.103041","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering exosome-based delivery of IL-37 to enhance cytokine stability and antitumor activity in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.103041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103041"}}